Pluri (PLUR) Other Non Operating Income (2010 - 2025)
Pluri (PLUR) reported Other Non Operating Income of -$143000.0 for Q4 2025, down 106.95% year-over-year from $2.1 million in Q4 2024, and down 132.57% quarter-over-quarter from $439000.0 in Q3 2025.
Pluri (PLUR) Other Non Operating Income (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 7 years of Other Non Operating Income data on file, last reported at -$143000.0 in Q4 2025.
- Other Non Operating Income for Q4 2025 came in at -$143000.0, down 106.95% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.3 million (down 619.37% YoY), and the FY2025 annual result was -$2.2 million, down 1811.9% from the prior year.
- Other Non Operating Income declined to -$143000.0 in Q4 2025 per PLUR's latest filing, from $439000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $2.1 million in Q4 2024 and troughed at -$2.9 million in Q2 2025.
- A 3-year average of -$173500.0 and a median of $109500.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income jumped 373.1% in 2024, then slumped 299.72% in 2025.
- A 3-year view of Other Non Operating Income shows it stood at $435000.0 in 2023, then jumped by 373.1% to $2.1 million in 2024, then slumped by 106.95% to -$143000.0 in 2025.
- Business Quant data shows PLUR's Other Non Operating Income at -$143000.0 in Q4 2025, $439000.0 in Q3 2025, and -$2.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -143,000.00 |
| Sep 30, 2025 | 439,000.00 |
| Jun 30, 2025 | -2.87 Mn |
| Mar 31, 2025 | -723,000.00 |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | -621,000.00 |
| Jun 30, 2024 | -1.16 Mn |
| Mar 31, 2024 | 362,000.00 |
| Dec 31, 2023 | 435,000.00 |
| Sep 30, 2023 | 493,000.00 |
| Sep 30, 2013 | 105,000.00 |
| Jun 30, 2013 | 226,000.00 |
| Mar 31, 2013 | 253,000.00 |
| Dec 31, 2012 | 394.00 |
| Sep 30, 2012 | 195,000.00 |
| Jun 30, 2012 | -164,000.00 |
| Mar 31, 2012 | 436,000.00 |
| Dec 31, 2011 | 126.00 |
| Sep 30, 2011 | -161,000.00 |
| Jun 30, 2011 | 112,000.00 |